News
Oxea Changes Name to OQ Chemicals
German petrochemical intermediates producer Oxea, based at Oberhausen, has changed its name to OQ Chemicals, marking its final integration into Oman’s new petrochemicals and energy giant OQ, headquartered in Muscat.
Azelis Buys Indonesia’s Primaditha
In another deal to boost its Asian footprint, Azelis has agreed to buy the distribution assets of Indonesia's PT Primaditha Jaya Mandiri.
Odfjell Sells Share in China Terminal
Odfjell Terminals (China), or OTC, part of Norwegian shipping and storage group Odfjell, has sold its 50% stake in its Dalian terminal in China to Dutch group VTTI Terminals for $59 million cash. The other 50% stake remains with the Port of Dalian. The move is part of Odfjell’s restructuring program.
Former GSK Vaccines Chief to Lead US Covid Sprint
Former head of GlaxoSmithKline's (GSK) vaccines division, Moncef Slaoui, has been named to lead the so-called "warp speed" effort to develop a coronavirus vaccine announced by US President Donald Trump at the beginning of May.
SABIC in Saudi Battery Joint Venture
SABIC’s Nusaned Investment unit has set up a joint venture with SCHMID Group to develop and manufacture vanadium redox flow batteries at Dammam 3rd Industrial City.
Pfizer to Make Space for Vaccine Production
To save manufacturing space for its growing vaccines plans, Pfizer has said it will outsource production of some of its pharmaceutical portfolio. The work is planned to be shared out with a network of 200 contractors in the US and Europe.
Menarini to Buy Stemline Therapeutics for $677 Million
Italian pharmaceuticals and diagnostics company Menarini is to buy US biopharma Stemline Therapeutics in a deal valued at up to $677 million.
